Intravesical Prostatic Protrusion in Prediction Outcome of Benign Prostatic Hyperplasia

Authors

  • Panu Tiensukon Division of Urology, Department of Surgery, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand
  • Bansithi Chaiyaprasithi Division of Urology, Department of Surgery, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand
  • Suchai Soontrapa Division of Urology, Department of Surgery, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand

Keywords:

Intravesical Prostatic Protrusion, Prediction Outcome, Benign Prostatic Hyperplasia

Abstract

In this study we evaluate the correlation between intravesical prostatic protrusion (IPP) and treatment outcome of benign prostatic hyperplasia (BPH).

A total of 43 patients with benign prostatic hyperplasia were evaluated by International Prostate Symptoms Score (IPSS), prostate volume, maximum flow rate, residual urine and IPP (measured by transrectal ultrasound).

Of 19 patients who underwent TURP and 24 patients who continued medication were evaluated. All patients with IPP less than 5 mm. continue their medication. If IPP between 5 to 8 mm. the chance for TURP is similar to medication but if IPP between 8 to10 mm. the risk for TURP is higher than 2 fold and if IPP is more than 10 mm. it will increase the risk for TURP by 4 fold.

Therefore IPP assessment is another useful indicator to predict treatment outcome.

References

McNeal J: Origin and evolution of benign prostatic enlargement. Invest Urol 1978; 15: 340-5.

Ochiai A, Kojima M. Correlation of ultrasound-estimated bladder weight with ultrasound appearance of the prostate and postvoid residual urine in men with lower urinary tract symptoms.Urology 1998; 51: 722-9.

Kuo HC. Clinical prostate score for diagnosis of bladder outlet obstruction by prostate measurements and uroflowmetry. Urology 1999; 54: 90-6.

Homma Y, Kawabe K, Tantiwong A, et al.Epidemiologic survey of Lower Urinary Tract Symptoms in ASIA and Australia using the International Prostate Symptom Score. Int Urol 1997; 4: 40-6.

Mastrigt RV, Pel JJM. Towards a noninvasive urodynamic diagnosis of infravesical obstruction. BJU Int 1999; 84: 195-203.

Abrams PH, Griffiths DJ. The assessment of prostatic obstruction from urodynamic measurement and from residual urine. Br J Urol 1979; 51: 129-34.

Netto NR, DûAncona CAL, Delima ML. Correlation between International Prostatic Symptom Score and a pressure flow study in the evaluation of symptomatic BPH. J Urol 1996; 155: 200-2.

El Din KE, Kiemeney LALM, De Wildt MJAM, Rosier PFWM, Debruyne FMJ, de la Rosette JJMCH. The correlation between bladder outlet obstruction and lower urinary tract symptoms as measured by the International Prostatic Symptom Score. J Urol 1996; 156: 1020-5.

ElDinKE,KiemeneyLALM,DeWildtMJAM,RosierPFWM,DebruyneFMJ,delaRosetteJJMCH.Correlationbetweenuroflowmetry, postvoided residual, and lower urinary tract symptoms as measured by the International Prostatic Symptom Score. Urology 1996; 48: 393-7.

Chia SJ, Heng CT. Correlation of intravesical prostatic protrusion with bladder outlet obstruction. Br J Urol 2003; 91: 371-4.

Downloads

Published

2006-06-01

How to Cite

Tiensukon, P., Chaiyaprasithi, B., & Soontrapa, S. (2006). Intravesical Prostatic Protrusion in Prediction Outcome of Benign Prostatic Hyperplasia. Insight Urology, 27(1), 21–25. Retrieved from https://he02.tci-thaijo.org/index.php/TJU/article/view/253744

Issue

Section

Original article